PRODUCT DETAILING IN THE PHARMA INDUSTRY final
Tools to Reduce Phase III Trial Failures Lawrence J. Lesko, Ph.D., FCP Director of the Office of Clinical Pharmacology and Biopharmaceutics Center for.
